CLOSEOUT LETTER
ICF International, LLC
- Recipient:
- ICF International, LLC
United States
- Issuing Office:
United States
| |
5001 Campus Drive College Park, MD 20740 |
May 23, 2017
Brandon Sojka
ICF International, LLC
President and CEO
840 Glynn Street South
Suite 338
Fayetteville, GA 30214
Dear Mr. Sojka,
The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter 483228, issued November 3, 2015. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Latasha A. Robinson, M.S.
Branch Chief
Dietary Supplement and Labeling
Assessment Branch
Division of Enforcement
Center for Food Safety and Applied Nutrition